Elizabeth Martin

A biomedical researcher with 20 years of experience in discovering signaling networks altered in human diseases.

Research Expertise

Endocrinology, Diabetes and Metabolism
Endocrinology
Oncology
Histology
Biomedical Engineering
Biotechnology
Bioengineering
Biochemistry
Cancer Research
Molecular Biology
Cell Biology
Structural Biology
Biophysics
Genetics
Metals and Alloys
Biomaterials
Ceramics and Composites
Molecular Medicine
Development
Anatomy
Clinical Biochemistry
Physiology
Physiology (medical)
Neurology (clinical)
Neurology
Psychiatry and Mental health
Rehabilitation
Hematology
Advanced and Specialized Nursing
Maternity and Midwifery
Obstetrics and Gynecology
Public Health, Environmental and Occupational Health
Developmental Biology
Pharmacology
Genetics (clinical)
Transplantation
Immunology
Immunology and Allergy
Atomic and Molecular Physics, and Optics
Condensed Matter Physics
Electrical and Electronic Engineering
Industrial and Manufacturing Engineering
Inorganic Chemistry
Catalysis
Organic Chemistry
Computer Science Applications
Physical and Theoretical Chemistry
Spectroscopy
Epidemiology
Materials Chemistry
Economics and Econometrics
Media Technology
Forestry

About

A biomedical researcher with 20 years of experience in discovering signaling networks altered in human diseases. Specializing in vitro, in vivo, and cell-based assays for drug and biomarker discovery. A strong track record of leading research teams in the evaluation of protein targets involved in cancer drug resistance and stem cell function.

Publications

Stromal cells and stem cells in clinical bone regeneration

Nature Reviews Endocrinology / Jan 06, 2015

Grayson, W. L., Bunnell, B. A., Martin, E., Frazier, T., Hung, B. P., & Gimble, J. M. (2015). Stromal cells and stem cells in clinical bone regeneration. Nature Reviews Endocrinology, 11(3), 140–150. https://doi.org/10.1038/nrendo.2014.234

Endocrine Disruptor Regulation of MicroRNA Expression in Breast Carcinoma Cells

PLoS ONE / Mar 05, 2012

Tilghman, S. L., Bratton, M. R., Segar, H. C., Martin, E. C., Rhodes, L. V., Li, M., McLachlan, J. A., Wiese, T. E., Nephew, K. P., & Burow, M. E. (2012). Endocrine Disruptor Regulation of MicroRNA Expression in Breast Carcinoma Cells. PLoS ONE, 7(3), e32754. https://doi.org/10.1371/journal.pone.0032754

Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration

Breast Cancer Research / Mar 14, 2012

Zhou, C., Zhong, Q., Rhodes, L. V., Townley, I., Bratton, M. R., Zhang, Q., Martin, E. C., Elliott, S., Collins-Burow, B. M., Burow, M. E., & Wang, G. (2012). Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration. Breast Cancer Research, 14(2). https://doi.org/10.1186/bcr3144

Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer

Oncotarget / Mar 21, 2015

Rhodes, L. V., Martin, E. C., Segar, H. C., Miller, D. F. B., Buechlein, A., Rusch, D. B., Nephew, K. P., Burow, M. E., & Collins-Burow, B. M. (2015). Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer. Oncotarget, 6(18), 16638–16652. https://doi.org/10.18632/oncotarget.3184

Engineering Breast Cancer Microenvironments and 3D Bioprinting

Frontiers in Bioengineering and Biotechnology / May 24, 2018

Belgodere, J. A., King, C. T., Bursavich, J. B., Burow, M. E., Martin, E. C., & Jung, J. P. (2018). Engineering Breast Cancer Microenvironments and 3D Bioprinting. Frontiers in Bioengineering and Biotechnology, 6. https://doi.org/10.3389/fbioe.2018.00066

The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells

Oncology Reports / Oct 04, 2011

Collins-Burow, B. (2011). The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells. Oncology Reports. https://doi.org/10.3892/or.2011.1488

MicroRNA regulation of stem cell differentiation and diseases of the bone and adipose tissue: Perspectives on miRNA biogenesis and cellular transcriptome

Biochimie / May 01, 2016

Martin, E. C., Qureshi, A. T., Dasa, V., Freitas, M. A., Gimble, J. M., & Davis, T. A. (2016). MicroRNA regulation of stem cell differentiation and diseases of the bone and adipose tissue: Perspectives on miRNA biogenesis and cellular transcriptome. Biochimie, 124, 98–111. https://doi.org/10.1016/j.biochi.2015.02.012

Preferential star strand biogenesis of pre‐miR‐24‐2 targets PKC‐alpha and suppresses cell survival in MCF‐7 breast cancer cells

Molecular Carcinogenesis / Aug 21, 2012

Martin, E. C., Elliott, S., Rhodes, L. V., Antoon, J. W., Fewell, C., Zhu, Y., Driver, J. L., Jodari‐Karimi, M., Taylor, C. W., Flemington, E. K., Beckman, B. S., Collins‐Burow, B. M., & Burow, M. E. (2012). Preferential star strand biogenesis of pre‐miR‐24‐2 targets PKC‐alpha and suppresses cell survival in MCF‐7 breast cancer cells. Molecular Carcinogenesis, 53(1), 38–48. Portico. https://doi.org/10.1002/mc.21946

Endocrine disruptors and the tumor microenvironment: A new paradigm in breast cancer biology

Molecular and Cellular Endocrinology / Dec 01, 2017

Burks, H., Pashos, N., Martin, E., Mclachlan, J., Bunnell, B., & Burow, M. (2017). Endocrine disruptors and the tumor microenvironment: A new paradigm in breast cancer biology. Molecular and Cellular Endocrinology, 457, 13–19. https://doi.org/10.1016/j.mce.2016.12.010

MEK5/ERK5 Signaling Suppresses Estrogen Receptor Expression and Promotes Hormone-Independent Tumorigenesis

PLoS ONE / Aug 09, 2013

Antoon, J. W., Martin, E. C., Lai, R., Salvo, V. A., Tang, Y., Nitzchke, A. M., Elliott, S., Nam, S. Y., Xiong, W., Rhodes, L. V., Collins-Burow, B., David, O., Wang, G., Shan, B., Beckman, B. S., Nephew, K. P., & Burow, M. E. (2013). MEK5/ERK5 Signaling Suppresses Estrogen Receptor Expression and Promotes Hormone-Independent Tumorigenesis. PLoS ONE, 8(8), e69291. https://doi.org/10.1371/journal.pone.0069291

Regulation of triple-negative breast cancer cell metastasis by the tumor-suppressor liver kinase B1

Oncogenesis / Oct 05, 2015

Rhodes, L. V., Tate, C. R., Hoang, V. T., Burks, H. E., Gilliam, D., Martin, E. C., Elliott, S., Miller, D. B., Buechlein, A., Rusch, D., Tang, H., Nephew, K. P., Burow, M. E., & Collins-Burow, B. M. (2015). Regulation of triple-negative breast cancer cell metastasis by the tumor-suppressor liver kinase B1. Oncogenesis, 4(10), e168–e168. https://doi.org/10.1038/oncsis.2015.27

MicroRNA‐335‐5p and ‐3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance

FEBS Letters / Jan 01, 2017

Martin, E. C., Conger, A. K., Yan, T. J., Hoang, V. T., Miller, D. F. B., Buechlein, A., Rusch, D. B., Nephew, K. P., Collins‐Burow, B. M., & Burow, M. E. (2017). MicroRNA‐335‐5p and ‐3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance. FEBS Letters, 591(2), 382–392. Portico. https://doi.org/10.1002/1873-3468.12538

Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition

International Journal of Oncology / Feb 08, 2013

ANTOON, J. W., NITZCHKE, A. M., MARTIN, E. C., RHODES, L. V., NAM, S., WADSWORTH, S., SALVO, V. A., ELLIOTT, S., COLLINS-BUROW, B., NEPHEW, K. P., & BUROW, M. E. (2013). Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition. International Journal of Oncology, 42(4), 1139–1150. https://doi.org/10.3892/ijo.2013.1814

Comparative proteomic analyses of human adipose extracellular matrices decellularized using alternative procedures

Journal of Biomedical Materials Research Part A / Sep 01, 2018

Thomas‐Porch, C., Li, J., Zanata, F., Martin, E. C., Pashos, N., Genemaras, K., Poche, J. N., Totaro, N. P., Bratton, M. R., Gaupp, D., Frazier, T., Wu, X., Ferreira, L. M., Tian, W., Wang, G., Bunnell, B. A., Flynn, L., Hayes, D., & Gimble, J. M. (2018). Comparative proteomic analyses of human adipose extracellular matrices decellularized using alternative procedures. Journal of Biomedical Materials Research Part A, 106(9), 2481–2493. Portico. https://doi.org/10.1002/jbm.a.36444

Transcriptomic Profiling of Adipose Derived Stem Cells Undergoing Osteogenesis by RNA-Seq

Scientific Reports / Aug 13, 2019

Shaik, S., Martin, E. C., Hayes, D. J., Gimble, J. M., & Devireddy, R. V. (2019). Transcriptomic Profiling of Adipose Derived Stem Cells Undergoing Osteogenesis by RNA-Seq. Scientific Reports, 9(1). https://doi.org/10.1038/s41598-019-48089-1

Altered Death Receptor Signaling Promotes Epithelial-to-Mesenchymal Transition and Acquired Chemoresistance

Scientific Reports / Jul 27, 2012

Antoon, J. W., Lai, R., Struckhoff, A. P., Nitschke, A. M., Elliott, S., Martin, E. C., Rhodes, L. V., Yoon, N. S., Salvo, V. A., Shan, B., Beckman, B. S., Nephew, K. P., & Burow, M. E. (2012). Altered Death Receptor Signaling Promotes Epithelial-to-Mesenchymal Transition and Acquired Chemoresistance. Scientific Reports, 2(1). https://doi.org/10.1038/srep00539

microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity

Molecular Cancer / Oct 06, 2014

Martin, E. C., Rhodes, L. V., Elliott, S., Krebs, A. E., Nephew, K. P., Flemington, E. K., Collins-Burow, B. M., & Burow, M. E. (2014). microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity. Molecular Cancer, 13(1). https://doi.org/10.1186/1476-4598-13-229

Insulin-Like Growth Factor-1 Signaling Regulates miRNA Expression in MCF-7 Breast Cancer Cell Line

PLoS ONE / Nov 30, 2012

Martin, E. C., Bratton, M. R., Zhu, Y., Rhodes, L. V., Tilghman, S. L., Collins-Burow, B. M., & Burow, M. E. (2012). Insulin-Like Growth Factor-1 Signaling Regulates miRNA Expression in MCF-7 Breast Cancer Cell Line. PLoS ONE, 7(11), e49067. https://doi.org/10.1371/journal.pone.0049067

miR-155 induced transcriptome changes in the MCF-7 breast cancer cell line leads to enhanced mitogen activated protein kinase signaling

Genes & Cancer / Oct 01, 2014

Martin, E. C., Krebs, A. E., Burks, H. E., Elliott, S., Baddoo, M., Collins-Burow, B. M., Flemington, E. K., & Burow, M. E. (2014). miR-155 induced transcriptome changes in the MCF-7 breast cancer cell line leads to enhanced mitogen activated protein kinase signaling. Genes & Cancer, 5(9–10), 353–364. https://doi.org/10.18632/genesandcancer.33

Evaluation of intercellular communication between breast cancer cells and adipose-derived stem cells via passive diffusion in a two-layer microfluidic device

Lab on a Chip / Jan 01, 2020

Rahman, S. M., Campbell, J. M., Coates, R. N., Render, K. M., Byrne, C. E., Martin, E. C., & Melvin, A. T. (2020). Evaluation of intercellular communication between breast cancer cells and adipose-derived stem cells via passive diffusion in a two-layer microfluidic device. Lab on a Chip, 20(11), 2009–2019. https://doi.org/10.1039/d0lc00142b

Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model

BMC Cancer / Mar 07, 2019

Matossian, M. D., Burks, H. E., Elliott, S., Hoang, V. T., Bowles, A. C., Sabol, R. A., Wahba, B., Anbalagan, M., Rowan, B., Abazeed, M. E., Bunnell, B. A., Moroz, K., Miele, L., Rhodes, L. V., Jones, S. D., Martin, E. C., Collins-Burow, B. M., & Burow, M. E. (2019). Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model. BMC Cancer, 19(1). https://doi.org/10.1186/s12885-019-5401-2

A novel patient-derived xenograft model for claudin-low triple-negative breast cancer

Breast Cancer Research and Treatment / Feb 01, 2018

Matossian, M. D., Burks, H. E., Bowles, A. C., Elliott, S., Hoang, V. T., Sabol, R. A., Pashos, N. C., O’Donnell, B., Miller, K. S., Wahba, B. M., Bunnell, B. A., Moroz, K., Zea, A. H., Jones, S. D., Ochoa, A. C., Al-Khami, A. A., Hossain, F., Riker, A. I., Rhodes, L. V., … Collins-Burow, B. M. (2018). A novel patient-derived xenograft model for claudin-low triple-negative breast cancer. Breast Cancer Research and Treatment, 169(2), 381–390. https://doi.org/10.1007/s10549-018-4685-2

Lignin-graft-PLGA drug-delivery system improves efficacy of MEK1/2 inhibitors in triple-negative breast cancer cell line

Nanomedicine / Apr 01, 2020

Byrne, C. E., Astete, C. E., Vaithiyanathan, M., Melvin, A. T., Moradipour, M., Rankin, S. E., Knutson, B. L., Sabliov, C. M., & Martin, E. C. (2020). Lignin-graft-PLGA drug-delivery system improves efficacy of MEK1/2 inhibitors in triple-negative breast cancer cell line. Nanomedicine, 15(10), 981–1000. https://doi.org/10.2217/nnm-2020-0010

Panobinostat suppresses the mesenchymal phenotype in a novel claudin-low triple negative patient-derived breast cancer model

Oncoscience / Apr 29, 2018

Matossian, M. D., Burks, H. E., Elliott, S., Hoang, V. T., Bowles, A. C., Sabol, R. A., Bunnell, B. A., Martin, E. C., Burow, M. E., & Collins-Burow, B. M. (2018). Panobinostat suppresses the mesenchymal phenotype in a novel claudin-low triple negative patient-derived breast cancer model. Oncoscience, 5(3–4), 99–108. https://doi.org/10.18632/oncoscience.412

The Relative Functionality of Freshly Isolated and Cryopreserved Human Adipose-Derived Stromal/Stem Cells

Cells Tissues Organs / Jan 01, 2016

Shah, F. S., Li, J., Zanata, F., Curley, J. L., Martin, E. C., Wu, X., Dietrich, M., Devireddy, R. V., Wade, J. W., & Gimble, J. M. (2016). The Relative Functionality of Freshly Isolated and Cryopreserved Human Adipose-Derived Stromal/Stem Cells. Cells Tissues Organs, 201(6), 436–444. Portico. https://doi.org/10.1159/000446494

Glyceollin, a novel regulator of mTOR/p70S6 in estrogen receptor positive breast cancer

The Journal of Steroid Biochemistry and Molecular Biology / Jun 01, 2015

Bratton, M. R., Martin, E. C., Elliott, S., Rhodes, L. V., Collins-Burow, B. M., McLachlan, J. A., Wiese, T. E., Boue, S. M., & Burow, M. E. (2015). Glyceollin, a novel regulator of mTOR/p70S6 in estrogen receptor positive breast cancer. The Journal of Steroid Biochemistry and Molecular Biology, 150, 17–23. https://doi.org/10.1016/j.jsbmb.2014.12.014

Evaluation of Extracellular Matrix Composition to Improve Breast Cancer Modeling

Tissue Engineering Part A / Apr 01, 2021

Byrne, C. E., Decombe, J.-B., Bingham, G. C., Remont, J., Miller, L. G., Khalif, L., King, C. T., Hamel, K., Bunnell, B. A., Burow, M. E., & Martin, E. C. (2021). Evaluation of Extracellular Matrix Composition to Improve Breast Cancer Modeling. Tissue Engineering Part A, 27(7–8), 500–511. https://doi.org/10.1089/ten.tea.2020.0364

A Role for Adipocytes and Adipose Stem Cells in the Breast Tumor Microenvironment and Regenerative Medicine

Frontiers in Physiology / Nov 29, 2021

Brock, C. K., Hebert, K. L., Artiles, M., Wright, M. K., Cheng, T., Windsor, G. O., Nguyen, K., Alzoubi, M. S., Collins-Burow, B. M., Martin, E. C., Lau, F. H., Bunnell, B. A., & Burow, M. E. (2021). A Role for Adipocytes and Adipose Stem Cells in the Breast Tumor Microenvironment and Regenerative Medicine. Frontiers in Physiology, 12. https://doi.org/10.3389/fphys.2021.751239

Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor

PLOS ONE / Oct 09, 2020

Chang, T. C., Matossian, M. D., Elliott, S., Burks, H. E., Sabol, R. A., Ucar, D. A., Wathieu, H., Zabaleta, J., Valle, L. D., Gill, S., Martin, E., Riker, A. I., Miele, L., Bunnell, B. A., Burow, M. E., & Collins-Burow, B. M. (2020). Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor. PLOS ONE, 15(10), e0226464. https://doi.org/10.1371/journal.pone.0226464

ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer

Frontiers in Oncology / Aug 03, 2020

Hoang, V. T., Matossian, M. D., Ucar, D. A., Elliott, S., La, J., Wright, M. K., Burks, H. E., Perles, A., Hossain, F., King, C. T., Browning, V. E., Bursavich, J., Fang, F., Del Valle, L., Bhatt, A. B., Cavanaugh, J. E., Flaherty, P. T., Anbalagan, M., Rowan, B. G., … Burow, M. E. (2020). ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer. Frontiers in Oncology, 10. https://doi.org/10.3389/fonc.2020.01164

Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor Alpha Isoform Variation

Non-Coding RNA / Sep 21, 2016

Conger, A., Martin, E., Yan, T., Rhodes, L., Hoang, V., La, J., Anbalagan, M., Burks, H., Rowan, B., Nephew, K., Collins-Burow, B., & Burow, M. (2016). Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor Alpha Isoform Variation. Non-Coding RNA, 2(3), 8. https://doi.org/10.3390/ncrna2030008

In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types

Clinical and Translational Oncology / Aug 09, 2021

Matossian, M. D., Chang, T., Wright, M. K., Burks, H. E., Elliott, S., Sabol, R. A., Wathieu, H., Windsor, G. O., Alzoubi, M. S., King, C. T., Bursavich, J. B., Ham, A. M., Savoie, J. J., Nguyen, K., Baddoo, M., Flemington, E., Sirenko, O., Cromwell, E. F., Hebert, K. L., … Burow, M. E. (2021). In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types. Clinical and Translational Oncology, 24(1), 127–144. https://doi.org/10.1007/s12094-021-02677-8

The effect of obesity on adipose-derived stromal cells and adipose tissue and their impact on cancer

Cancer and Metastasis Reviews / Aug 24, 2022

Bunnell, B. A., Martin, E. C., Matossian, M. D., Brock, C. K., Nguyen, K., Collins-Burow, B., & Burow, M. E. (2022). The effect of obesity on adipose-derived stromal cells and adipose tissue and their impact on cancer. Cancer and Metastasis Reviews, 41(3), 549–573. https://doi.org/10.1007/s10555-022-10063-1

Quantifying Breast Cancer-Driven Fiber Alignment and Collagen Deposition in Primary Human Breast Tissue

Frontiers in Bioengineering and Biotechnology / Mar 15, 2021

Gurrala, R., Byrne, C. E., Brown, L. M., Tiongco, R. F. P., Matossian, M. D., Savoie, J. J., Collins-Burow, B. M., Burow, M. E., Martin, E. C., & Lau, F. H. (2021). Quantifying Breast Cancer-Driven Fiber Alignment and Collagen Deposition in Primary Human Breast Tissue. Frontiers in Bioengineering and Biotechnology, 9. https://doi.org/10.3389/fbioe.2021.618448

Trauma induced heterotopic ossification patient serum alters mitogen activated protein kinase signaling in adipose stem cells

Journal of Cellular Physiology / Apr 10, 2018

Martin, E. C., Qureshi, A. T., Llamas, C. B., Boos, E. C., King, A. G., Krause, P. C., Lee, O. C., Dasa, V., Freitas, M. A., Forsberg, J. A., Elster, E. A., Davis, T. A., & Gimble, J. M. (2018). Trauma induced heterotopic ossification patient serum alters mitogen activated protein kinase signaling in adipose stem cells. Journal of Cellular Physiology, 233(9), 7035–7044. Portico. https://doi.org/10.1002/jcp.26504

Mirna biogenesis pathway is differentially regulated during adipose derived stromal/stem cell differentiation

Adipocyte / Feb 07, 2018

Martin, E. C., Qureshi, A. T., Llamas, C. B., Burow, M. E., King, A. G., Lee, O. C., Dasa, V., Freitas, M. A., Forsberg, J. A., Elster, E. A., Davis, T. A., & Gimble, J. M. (2018). Mirna biogenesis pathway is differentially regulated during adipose derived stromal/stem cell differentiation. Adipocyte, 1–10. https://doi.org/10.1080/21623945.2018.1423911

Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy

Annals of Oncology / Mar 01, 2012

Campone, M., Bondarenko, I., Brincat, S., Hotko, Y., Munster, P. N., Chmielowska, E., Fumoleau, P., Ward, R., Bardy-Bouxin, N., Leip, E., Turnbull, K., Zacharchuk, C., & Epstein, R. J. (2012). Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy. Annals of Oncology, 23(3), 610–617. https://doi.org/10.1093/annonc/mdr261

Self‐injurious behaviours in rhesus macaques: Potential glial mechanisms

Journal of Intellectual Disability Research / Nov 19, 2018

Ramsey, J., Martin, E. C., Purcell, O. M., Lee, K. M., & MacLean, A. G. (2018). Self‐injurious behaviours in rhesus macaques: Potential glial mechanisms. Journal of Intellectual Disability Research, 62(12), 1008–1017. Portico. https://doi.org/10.1111/jir.12558

Generation of 3D Spheroids Using a Thiol–Acrylate Hydrogel Scaffold to Study Endocrine Response in ER+ Breast Cancer

ACS Biomaterials Science & Engineering / Aug 24, 2022

Khan, A. H., Zhou, S. P., Moe, M., Ortega Quesada, B. A., Bajgiran, K. R., Lassiter, H. R., Dorman, J. A., Martin, E. C., Pojman, J. A., & Melvin, A. T. (2022). Generation of 3D Spheroids Using a Thiol–Acrylate Hydrogel Scaffold to Study Endocrine Response in ER+ Breast Cancer. ACS Biomaterials Science & Engineering, 8(9), 3977–3985. https://doi.org/10.1021/acsbiomaterials.2c00491

Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer

Women's Health Reports / Apr 01, 2020

Matossian, M. D., Giardina, A. A., Wright, M. K., Elliott, S., Loch, M. M., Nguyen, K., Zea, A. H., Lau, F. H., Moroz, K., Riker, A. I., Jones, S. D., Martin, E. C., Bunnell, B. A., Miele, L., Collins-Burow, B. M., & Burow, M. E. (2020). Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer. Women’s Health Reports, 1(1), 383–392. https://doi.org/10.1089/whr.2020.0037

Acellular Biologic Nipple–Areolar Complex Graft: In Vivo Murine and Nonhuman Primate Host Response Evaluation

Tissue Engineering Part A / Aug 01, 2020

Pashos, N. C., Graham, D. M., Burkett, B. J., O’Donnell, B., Sabol, R. A., Helm, J., Martin, E. C., Bowles, A. C., Heim, W. M., Caronna, V. C., Miller, K. S., Grasperge, B., Sullivan, S., Chaffin, A. E., & Bunnell, B. A. (2020). Acellular Biologic Nipple–Areolar Complex Graft: In Vivo Murine and Nonhuman Primate Host Response Evaluation. Tissue Engineering Part A, 26(15–16), 872–885. https://doi.org/10.1089/ten.tea.2019.0222

Adipose-Derived Stromal/Stem Cell Response to Tumors and Wounds: Evaluation of Patient Age

Stem Cells and Development / Oct 01, 2022

Hamel, K. M., Liimatta, K. Q., Belgodere, J. A., Bunnell, B. A., Gimble, J. M., & Martin, E. C. (2022). Adipose-Derived Stromal/Stem Cell Response to Tumors and Wounds: Evaluation of Patient Age. Stem Cells and Development, 31(19–20), 579–592. https://doi.org/10.1089/scd.2021.0280

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Journal of Visualized Experiments / Apr 23, 2021

Brown, L. M., Hebert, K. L., Gurrala, R. R., Byrne, C. E., Burow, M., Martin, E. C., & Lau, F. H. (2021). Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System. Journal of Visualized Experiments, 170. https://doi.org/10.3791/62009

Breast Cancer-Stromal Interactions: Adipose-Derived Stromal/Stem Cell Age and Cancer Subtype Mediated Remodeling

Stem Cells and Development / Oct 01, 2022

Hamel, K. M., King, C. T., Cavalier, M. B., Liimatta, K. Q., Rozanski, G. L., King, T. A., Lam, M., Bingham, G. C., Byrne, C. E., Xing, D., Collins-Burow, B. M., Burow, M. E., Belgodere, J. A., Bratton, M. R., Bunnell, B. A., & Martin, E. C. (2022). Breast Cancer-Stromal Interactions: Adipose-Derived Stromal/Stem Cell Age and Cancer Subtype Mediated Remodeling. Stem Cells and Development, 31(19–20), 604–620. https://doi.org/10.1089/scd.2021.0279

microRNA Sequencing of CD34+ Sorted Adipose Stem Cells Undergoing Endotheliogenesis

Stem Cells and Development / Mar 01, 2021

Shaik, S., Martin, E., Hayes, D., Gimble, J., & Devireddy, R. (2021). microRNA Sequencing of CD34+ Sorted Adipose Stem Cells Undergoing Endotheliogenesis. Stem Cells and Development, 30(5), 265–288. https://doi.org/10.1089/scd.2020.0173

Comparative Analysis of Human Adipose-Derived Stromal/Stem Cells and Dermal Fibroblasts

Stem Cells and Development / Dec 01, 2021

Zanata, F., Curley, L., Martin, E., Bowles, A., Bunnell, B. A., Wu, X., Ferreira, L. M., & Gimble, J. M. (2021). Comparative Analysis of Human Adipose-Derived Stromal/Stem Cells and Dermal Fibroblasts. Stem Cells and Development, 30(23), 1171–1178. https://doi.org/10.1089/scd.2021.0164

Breast Cancer Reconstruction: Design Criteria for a Humanized Microphysiological System

Tissue Engineering Part A / Apr 01, 2021

Frazier, T., Williams, C., Henderson, M., Duplessis, T., Rogers, E., Wu, X., Hamel, K., Martin, E. C., Mohiuddin, O., Shaik, S., Devireddy, R., Rowan, B. G., Hayes, D. J., & Gimble, J. M. (2021). Breast Cancer Reconstruction: Design Criteria for a Humanized Microphysiological System. Tissue Engineering Part A, 27(7–8), 479–488. https://doi.org/10.1089/ten.tea.2020.0372

Adipose-Derived Stem/Stromal Cells

Regenerative Medicine - from Protocol to Patient / Jan 01, 2016

Li, J., Martin, E. C., & Gimble, J. M. (2016). Adipose-Derived Stem/Stromal Cells. In Regenerative Medicine - from Protocol to Patient (pp. 363–387). Springer International Publishing. https://doi.org/10.1007/978-3-319-27610-6_14

LKB1 signaling and patient survival outcomes in hepatocellular carcinoma

Pharmacological Research / Jun 01, 2023

Nguyen, K., Hebert, K., McConnell, E., Cullen, N., Cheng, T., Awoyode, S., Martin, E., Chen, W., Wu, T., Alahari, S. K., Izadpanah, R., Collins-Burow, B. M., Lee, S. B., Drewry, D. H., & Burow, M. E. (2023). LKB1 signaling and patient survival outcomes in hepatocellular carcinoma. Pharmacological Research, 192, 106757. https://doi.org/10.1016/j.phrs.2023.106757

Liver Kinase B1 Regulates Remodeling of the Tumor Microenvironment in Triple-Negative Breast Cancer

Frontiers in Molecular Biosciences / Jun 08, 2022

King, C. T., Matossian, M. D., Savoie, J. J., Nguyen, K., Wright, M. K., Byrne, C. E., Elliott, S., Burks, H. E., Bratton, M. R., Pashos, N. C., Bunnell, B. A., Burow, M. E., Collins-Burow, B. M., & Martin, E. C. (2022). Liver Kinase B1 Regulates Remodeling of the Tumor Microenvironment in Triple-Negative Breast Cancer. Frontiers in Molecular Biosciences, 9. https://doi.org/10.3389/fmolb.2022.847505

Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant‑resistant phenotype in breast cancer cells

Oncology Letters / Mar 16, 2021

Matossian, M., Elliott, S., Rhodes, L., Martin, E., Hoang, V., Burks, H., Zuercher, W., Drewry, D., Collins‑Burow, B., & Burow, M. (2021). Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant‑resistant phenotype in breast cancer cells. Oncology Letters, 21(5). https://doi.org/10.3892/ol.2021.12641

Proteomic characterization of a trauma-based rat model of heterotopic ossification identifies interactive signaling networks as potential therapeutic targets

Journal of Proteomics / Aug 01, 2020

Hoover, M. E., Martin, E. C., Llamas, C. B., Qureshi, A., Davis, T. A., Gimble, J. M., & Freitas, M. A. (2020). Proteomic characterization of a trauma-based rat model of heterotopic ossification identifies interactive signaling networks as potential therapeutic targets. Journal of Proteomics, 226, 103907. https://doi.org/10.1016/j.jprot.2020.103907

Using an in vitro fluidics approach to model the evolution of metastatic breast cancer reveals shear stress as a possible driver of genomic instability and somatic mutation

The FASEB Journal / Apr 01, 2019

Bratton, M., Byrne, C. E., Rahman, S. M., King, C. T., Copeland, C. E., Rhodes, L., Glotser, E., Ma, P., Skripnikova, E., Wiese, T., Melvin, A., & Martin, E. (2019). Using an in vitro fluidics approach to model the evolution of metastatic breast cancer reveals shear stress as a possible driver of genomic instability and somatic mutation. The FASEB Journal, 33(S1). Portico. https://doi.org/10.1096/fasebj.2019.33.1_supplement.lb175

Age-dependent modulation of the extracellular microenvironment of human adipose-derived stem cells

Cytotherapy / May 01, 2018

Hamel, K. M., Gimble, J., Jung, J. P., & Martin, E. C. (2018). Age-dependent modulation of the extracellular microenvironment of human adipose-derived stem cells. Cytotherapy, 20(5), S85. https://doi.org/10.1016/j.jcyt.2018.02.241

Abstract 3906: Ex vivo breast tumors for understanding the patient specific tumor microenvironment remodeling and drug responses

Cancer Research / Mar 22, 2024

Martin, E., Benz, M., Hebert, K., Byrne, E., & Lau, F. (2024). Abstract 3906: Ex vivo breast tumors for understanding the patient specific tumor microenvironment remodeling and drug responses. Cancer Research, 84(6_Supplement), 3906–3906. https://doi.org/10.1158/1538-7445.am2024-3906

A modular microfluidic platform to study how fluid shear stress alters estrogen receptor phenotype in ER+ breast cancer cells

Microsystems & Nanoengineering / Feb 16, 2024

Ortega Quesada, B. A., Cuccia, J., Coates, R., Nassar, B., Littlefield, E., Martin, E. C., & Melvin, A. T. (2024). A modular microfluidic platform to study how fluid shear stress alters estrogen receptor phenotype in ER+ breast cancer cells. Microsystems & Nanoengineering, 10(1). https://doi.org/10.1038/s41378-024-00653-0

Enhanced Angiogenesis in HUVECs Preconditioned with Media from Adipocytes Differentiated from Lipedema Adipose Stem Cells In Vitro

International Journal of Molecular Sciences / Sep 01, 2023

Al-Ghadban, S., Walczak, S. G., Isern, S. U., Martin, E. C., Herbst, K. L., & Bunnell, B. A. (2023). Enhanced Angiogenesis in HUVECs Preconditioned with Media from Adipocytes Differentiated from Lipedema Adipose Stem Cells In Vitro. International Journal of Molecular Sciences, 24(17), 13572. https://doi.org/10.3390/ijms241713572

A modular microfluidic platform to study how fluid shear stress alters estrogen receptor phenotype in ER+ breast cancer cells

Oct 10, 2023

Melvin, A., Quesada, B. O., Cuccia, J., Coates, R., Nassar, B., Littlefield, E., & Martin, E. (2023). A modular microfluidic platform to study how fluid shear stress alters estrogen receptor phenotype in ER+ breast cancer cells. https://doi.org/10.21203/rs.3.rs-3399118/v1

Co-culture of Two Different Cell Lines in a Two-Layer Microfluidic Device

Methods in Molecular Biology / Jan 01, 2022

Rahman, S. M., Martin, E. C., & Melvin, A. T. (2022). Co-culture of Two Different Cell Lines in a Two-Layer Microfluidic Device. In Cancer Drug Resistance (pp. 33–47). Springer US. https://doi.org/10.1007/978-1-0716-2513-2_3

Abstract 282: Breast cancer microphysiological systems based on human breast tissue

Cancer Research / Jun 15, 2022

Lau, F. H., Byrne, C. E., Brown, L., Fontenot, J., Tiongco, R. P., Gurrala, R. R., Cuccia, J., DiNardo, A., Burow, M., & Martin, E. C. (2022). Abstract 282: Breast cancer microphysiological systems based on human breast tissue. Cancer Research, 82(12_Supplement), 282–282. https://doi.org/10.1158/1538-7445.am2022-282

Abstract 3831: Utilizing decellularized triple-negative breast cancer patient-derived tumor models as drug testing platforms

Cancer Research / Jun 15, 2022

Wright, M., Nguyen, K., Martin, E., Bratton, M., Collins-Burow, B., & Burow, M. (2022). Abstract 3831: Utilizing decellularized triple-negative breast cancer patient-derived tumor models as drug testing platforms. Cancer Research, 82(12_Supplement), 3831–3831. https://doi.org/10.1158/1538-7445.am2022-3831

235 Analysiss of TNBC Cell Lines Cultured a Novel Translational Breast Cancer Microphysiological System (BC-MPS)

Journal of Clinical and Translational Science / Apr 01, 2022

Hebert, K. L., Nguyen, K., Cheng, T., Alzoubi, M., Elliott, S., Collins-Burow, B., Martin, E., Lau, F., & Burow, M. (2022). 235 Analysiss of TNBC Cell Lines Cultured a Novel Translational Breast Cancer Microphysiological System (BC-MPS). Journal of Clinical and Translational Science, 6(s1), 37–37. https://doi.org/10.1017/cts.2022.124

Abstract P5-02-03: Phenotypic analysis for TNBC using a novel breast cancer microphysiological system

Cancer Research / Feb 15, 2022

Hebert, K., Nguyen, K., Cheng, T., Alzoubi, M., Collins-Burow, B., Martin, E., Lau, F., & Burow, M. (2022). Abstract P5-02-03: Phenotypic analysis for TNBC using a novel breast cancer microphysiological system. Cancer Research, 82(4_Supplement), P5-02-03-P5-02–03. https://doi.org/10.1158/1538-7445.sabcs21-p5-02-03

Abstract P3-01-16: Utilizing a decellularized patient-derived xenograft tumor model for the evaluation of triple negative breast cancer

Cancer Research / Feb 15, 2020

Wright, M., Matossian, M., King, C., Nguyen, K., Elliott, S., Alzoubi, M., Martin, E., Collins-Burow, B., & Burow, M. (2020). Abstract P3-01-16: Utilizing a decellularized patient-derived xenograft tumor model for the evaluation of triple negative breast cancer. Cancer Research, 80(4_Supplement), P3-01-16-P3-01–16. https://doi.org/10.1158/1538-7445.sabcs19-p3-01-16

Commonwealth Bank - Head Office cnr Pitt Street & Martin Place - Construction - View from Martin Place (Street level) - 18 April 1916 (plate 630)

Mar 08, 2021

Commonwealth Bank - Head Office cnr Pitt Street & Martin Place - Construction - View from Martin Place (Street level) - 18 April 1916 (plate 630). (2021). Reserve Bank of Australia. https://doi.org/10.47688/rba_archives_pn-000794

Abstract 80: Utilizing a decellularized PDX tumor matrix model to investigate LKB1 regulation of ECM remodeling in TNBC

Cancer Research / Jul 01, 2021

Wright, M., Matossian, M., Alzoubi, M., King, C., Elliott, S., Bratton, M., Martin, E., Collins-Burow, B., & Burow, M. (2021). Abstract 80: Utilizing a decellularized PDX tumor matrix model to investigate LKB1 regulation of ECM remodeling in TNBC. Cancer Research, 81(13_Supplement), 80–80. https://doi.org/10.1158/1538-7445.am2021-80

Correction: Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor

PLOS ONE / Apr 29, 2021

Chang, T. C., Matossian, M. D., Elliott, S., Burks, H. E., Sabol, R. A., Ucar, D. A., Wathieu, H., Zabaleta, J., Valle, L. D., Gill, S., Martin, E., Riker, A. I., Miele, L., Bunnell, B. A., Burow, M. E., & Collins-Burow, B. M. (2021). Correction: Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor. PLOS ONE, 16(4), e0251106. https://doi.org/10.1371/journal.pone.0251106

Abstract C110: Applications of patient-derived triple-negative breast cancer xenografts that represent understudied patients in Louisiana in targeted therapeutic research

Cancer Epidemiology, Biomarkers & Prevention / Jun 01, 2020

Matossian, M. D., Elliott, S., Burks, H. E., Wright, M., Sabol, R. A., Hoang, V. T., Ucar, D. A., Alfortish, A., Zabaleta, J., Hossain, F., Chang, T., Wathieu, H., Pashos, N., Bunnell, B., Moroz, K., Zea, A., Riker, A., Jones, S. D., Martin, E. C., … Burow, M. E. (2020). Abstract C110: Applications of patient-derived triple-negative breast cancer xenografts that represent understudied patients in Louisiana in targeted therapeutic research. Cancer Epidemiology, Biomarkers & Prevention, 29(6_Supplement_1), C110–C110. https://doi.org/10.1158/1538-7755.disp18-c110

Abstract P6-03-17: Effect of histone deacetylase inhibitors on patient-derived neoadjuvant chemotherapy resistant triple negative breast cancer xenografts that represent understudied patients

Cancer Research / Feb 15, 2020

Matossian, M., Elliott, S., Wright, M., Chang, T., Alzoubi, M., Wathieu, H., Sabol, R., Alfortish, A., Burks, H., Hoang, V., Ucar, D., Windsor, G., Yan, T., Zabaleta, J., Hossain, F., Bunnell, B., Moroz, K., Zea, A., Riker, A., … Burow, M. (2020). Abstract P6-03-17: Effect of histone deacetylase inhibitors on patient-derived neoadjuvant chemotherapy resistant triple negative breast cancer xenografts that represent understudied patients. Cancer Research, 80(4_Supplement), P6-03-17-P6-03–17. https://doi.org/10.1158/1538-7445.sabcs19-p6-03-17

Abstract A105: Novel lignin-conjugated PLGA drug delivery system improves efficacy of MEK1/2 inhibitor in triple negative breast cancer

Molecular Cancer Therapeutics / Dec 01, 2019

Byrne, E., Astete, C. E., Vaithiyanathan, M., Melvin, A. T., Moradipour, M., Rankin, S. E., Knutson, B. L., Martin, E. C., & Sabliov, C. (2019). Abstract A105: Novel lignin-conjugated PLGA drug delivery system improves efficacy of MEK1/2 inhibitor in triple negative breast cancer. Molecular Cancer Therapeutics, 18(12_Supplement), A105–A105. https://doi.org/10.1158/1535-7163.targ-19-a105

Adaptable microfluidic device improves the measurement of cancer cell migration and trapping

Scilight / Aug 29, 2019

Mandel, S. (2019). Adaptable microfluidic device improves the measurement of cancer cell migration and trapping. Scilight, 2019(35). https://doi.org/10.1063/1.5123602

Abstract 4236: Evaluating alterations in mRNA biogenesis with TCGA breast cancer sequencing data

Cancer Research / Jul 01, 2019

Yan, T. J., Burow, M. E., & Martin, E. C. (2019). Abstract 4236: Evaluating alterations in mRNA biogenesis with TCGA breast cancer sequencing data. Cancer Research, 79(13_Supplement), 4236–4236. https://doi.org/10.1158/1538-7445.am2019-4236

Abstract 1385: In vitro evaluation of platinum chemotherapy combinations with the ATR inhibitor, ceralasertib (AZD6738)

Cancer Research / Aug 15, 2020

Hall, S. E., Lau, A., Dean, E., Martin, E., Ottley, C., Drew, Y., & Veal, G. (2020). Abstract 1385: In vitro evaluation of platinum chemotherapy combinations with the ATR inhibitor, ceralasertib (AZD6738). Cancer Research, 80(16_Supplement), 1385–1385. https://doi.org/10.1158/1538-7445.am2020-1385

Abstract A01: Application of patient-derived models from understudied patient populations to discover therapeutically targetable pathways in triple-negative breast cancer systems

Molecular Cancer Research / Aug 01, 2018

Matossian, M., Burks, H., Chang, T., Bowles, A., Sabol, R., Hoang, V., Bunnell, B., Alfortish, A., Moroz, K., Zea, A., Riker, A., Jones, S., Bilyeu, A. D. U., Hossain, F., Miller, K., Martin, E., O’Donnell, B., Pashos, N., Miele, L., … Collins-Burow, B. (2018). Abstract A01: Application of patient-derived models from understudied patient populations to discover therapeutically targetable pathways in triple-negative breast cancer systems. Molecular Cancer Research, 16(8_Supplement), A01–A01. https://doi.org/10.1158/1557-3125.advbc17-a01

Abstract 4410: ZEB2 drives cell motility and metastasis in ER+ breast cancer cells through a novel, E-cadherin independent pathway

Cancer Research / Jul 15, 2016

Burks, H. E., Rhodes, L. V., Martin, E. C., Hoang, V. T., Elliott, S., Badoo, M., Phamduy, T., Buechlein, A., Rusch, D., Chrisey, D., Flemington, E., Nephew, K., Collins-Burow, B., & Burow, M. E. (2016). Abstract 4410: ZEB2 drives cell motility and metastasis in ER+ breast cancer cells through a novel, E-cadherin independent pathway. Cancer Research, 76(14_Supplement), 4410–4410. https://doi.org/10.1158/1538-7445.am2016-4410

Abstract 1596: Induction of mesenchymal-to-epithelial transition through pan-MEK inhibition in triple-negative breast cancer

Cancer Research / Jul 15, 2016

Hoang, V. T., Elliott, S., Martin, E. C., Rhodes, L. V., Burks, H. E., Matossian, M., Chakrabarty, S., Monlish, D., Phamduy, T. B., Curley, L., Anbalagan, M., Rowan, B. G., Chrisey, D., Cavanaugh, J. E., Flaherty, P. T., Collins-Burow, B. M., & Burow, M. E. (2016). Abstract 1596: Induction of mesenchymal-to-epithelial transition through pan-MEK inhibition in triple-negative breast cancer. Cancer Research, 76(14_Supplement), 1596–1596. https://doi.org/10.1158/1538-7445.am2016-1596

Abstract 5096: Development of a decellularized tumor model for the evaluation of breast carcinomas

Cancer Research / Jul 15, 2016

Martin, E., Pashos, N., Gimble, J., Bunnell, B., Burow, M., & Collins-Burow, B. (2016). Abstract 5096: Development of a decellularized tumor model for the evaluation of breast carcinomas. Cancer Research, 76(14_Supplement), 5096–5096. https://doi.org/10.1158/1538-7445.am2016-5096

Abstract 1571: The tumor suppressor Liver Kinase B1 inhibits triple-negative breast cancer cell metastasis via regulation of AP-1 signaling

Cancer Research / Oct 01, 2014

Rhodes, L. V., Tate, C. R., Burks, H. E., Hoang, V. T., Gilliam, D., Martin, E. C., Elliott, S., Miller, D. F., Buechlein, A., Rusch, D., Tang, H., Nephew, K. P., Burow, M. E., & Collins-Burow, B. M. (2014). Abstract 1571: The tumor suppressor Liver Kinase B1 inhibits triple-negative breast cancer cell metastasis via regulation of AP-1 signaling. Cancer Research, 74(19_Supplement), 1571–1571. https://doi.org/10.1158/1538-7445.am2014-1571

Abstract 1052: Dual role of MEK1/2 and MEK5 in the reversal of epithelial-to-mesenchymal transition

Cancer Research / Oct 01, 2014

Hoang, V. T., Elliott, S., Martin, E. C., Rhodes, L. V., Segar, H. C., Burks, H., Chakrabarty, S., Monlish, D., Phamduy, T. B., Chrisey, D., Cavanaugh, J. E., Flaherty, P., Collins-Burow, B. M., & Burow, M. E. (2014). Abstract 1052: Dual role of MEK1/2 and MEK5 in the reversal of epithelial-to-mesenchymal transition. Cancer Research, 74(19_Supplement), 1052–1052. https://doi.org/10.1158/1538-7445.am2014-1052

Abstract 1034: ZEB2 promotes cell motility and metastasis in ER+ breast cancer cells

Cancer Research / Oct 01, 2014

Burks, H. E., Rhodes, L., Martin, E., Phamduy, T., Elliot, S., Hoang, V., Segar, H., Buechlein, A., Rusch, D., Miller, D., Baddoo, M., Flemington, E., Nephew, K., Chrisey, D., Collins-Burow, B., & Burow, M. (2014). Abstract 1034: ZEB2 promotes cell motility and metastasis in ER+ breast cancer cells. Cancer Research, 74(19_Supplement), 1034–1034. https://doi.org/10.1158/1538-7445.am2014-1034

Tulane/Xavier Vaccine Peptide Program

Jul 01, 2013

Clements, J. D. (2013). Tulane/Xavier Vaccine Peptide Program. Defense Technical Information Center. https://doi.org/10.21236/ada615102

Education

Tulane University

PhD, Biomedical Sciences / December, 2013

New Orleans, Louisiana, United States of America

Experience

Louisiana State University

Assistant Professor Biological Engineering / 20162022

Tulane University

Associate Professor / 2023Present

Join Elizabeth on NotedSource!
Join Now

At NotedSource, we believe that professors, post-docs, scientists and other researchers have deep, untapped knowledge and expertise that can be leveraged to drive innovation within companies. NotedSource is committed to bridging the gap between academia and industry by providing a platform for collaboration with industry and networking with other researchers.

For industry, NotedSource identifies the right academic experts in 24 hours to help organizations build and grow. With a platform of thousands of knowledgeable PhDs, scientists, and industry experts, NotedSource makes connecting and collaborating easy.

For academic researchers such as professors, post-docs, and Ph.D.s, NotedSource provides tools to discover and connect to your colleagues with messaging and news feeds, in addition to the opportunity to be paid for your collaboration with vetted partners.

Expert Institutions
NotedSource has experts from Stanford University
Expert institutions using NotedSource include Oxfort University
Experts from McGill have used NotedSource to share their expertise
University of Chicago experts have used NotedSource
MIT researchers have used NotedSource
Proudly trusted by
Microsoft uses NotedSource for academic partnerships
Johnson & Johnson academic research projects on NotedSource
ProQuest (Clarivate) uses NotedSource as their industry academia platform
Slamom consulting engages academics for research collaboration on NotedSource
Omnicom and OMG find academics on notedsource
Unilever research project have used NotedSource to engage academic experts